Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Bone Remodeling and Repair

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis.

Annals of the rheumatic diseases·2023

Same author

Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study.

Annals of the rheumatic diseases·2023

Same author

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries.

Joint bone spine·2022

Same author

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis.

Annals of the rheumatic diseases·2022

Same author

Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.

Seminars in arthritis and rheumatism·2022

Same author

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.

Annals of the rheumatic diseases·2022

Search research articles

Related Experiment Video

Updated: May 24, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Inflammatory bone loss: pathogenesis and therapeutic intervention.

Kurt Redlich¹, Josef S Smolen

¹Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. kurt.redlich@meduniwien.ac.at

Nature Reviews. Drug Discovery

|March 2, 2012

Summary

This summary is machine-generated.

Chronic inflammation disrupts bone remodeling, leading to bone loss and increased fracture risk. This review explores the underlying mechanisms and therapeutic strategies for managing inflammatory bone loss.

Related Experiment Videos

Last Updated: May 24, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Area of Science:

Bone Biology and Metabolism
Immunology and Inflammation
Endocrinology

Background:

Bone undergoes continuous remodeling, a process susceptible to hormonal and inflammatory disruptions.
Chronic inflammation, regardless of origin, significantly impacts bone metabolism, often resulting in increased bone loss and fracture risk.
Examples of inflammatory conditions affecting bone include rheumatoid arthritis, inflammatory bowel disease, periodontitis, and cystic fibrosis.

Purpose of the Study:

To elucidate the cellular and signaling pathways involved in inflammation-induced bone loss.
To review current and potential therapeutic strategies for mitigating bone loss in the context of chronic inflammatory diseases.

Main Methods:

Literature review of cellular and molecular mechanisms.
Analysis of signaling pathways implicated in bone remodeling and inflammation.
Examination of therapeutic interventions targeting inflammatory bone loss.

Main Results:

Inflammatory mediators disrupt the balance between bone formation and resorption.
Specific signaling pathways (e.g., involving cytokines like TNF-α and IL-6) are key drivers of bone loss.
Therapeutic strategies aim to modulate inflammatory responses or directly target bone cells.

Conclusions:

Inflammation is a critical factor in bone loss and increased fracture risk across various diseases.
Understanding the molecular basis of inflammatory bone loss is crucial for developing effective treatments.
Targeting inflammatory pathways offers promising therapeutic avenues for preserving bone health.